The integrated approach is designed to adapt to the evolving needs of new therapeutic modalities, delivering both speed and performance.

The key for optimizing cell-line development for antibody derivatives might just be to prioritize early assessment of product ...

Successfully producing large quantities of biotherapeutics, including monoclonal antibodies and recombinant protein products, depends on robust and reliable cell line development (CLD). Issues that ...

OneCyte, a leader in high-throughput single-cell analysis and cell line development technologies, and Kemp Proteins, a ...

New offering provides drug developers with flexible and powerful cell line development options for monoclonal antibodies, multi-specific and complex molecules SEATTLE--(BUSINESS WIRE)-- As drug ...

At Hayward Field, the roar of the crowd is familiar, not just from collegiate competition, but from years of growing up in the stands, watching,... Think about your favorite medicine. Maybe it is a ...

Discover how to streamline your cell line development process for recombinant protein and monoclonal antibody production with this in-depth eBook. Whether you're working with CHO, HEK293, or hybridoma ...

SHANGHAI, Aug. 11, 2025 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the launch of WuXia293 Stable ...

New GMP-grade cell lines with outstanding growth profile outperform industry standards and enable rapid growth performance for cell and gene therapies COLLEGE STATION, Texas--(BUSINESS WIRE)--Matica ...

Biologics and cell therapy programs face increasing pressure to generate high-quality cell lines and physiologically relevant 3D models, faster and with greater reproducibility. Integrated automation ...

During a cell line development project, Agenus UK used the Amperia platform in combination with BLI and SPR to analyze antibody titers. The study found a good correlation between the platforms and ...